Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-05

Clinical Trial Update: Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist [Phase 2]

View source ↗

Summary

Phase 2 trial results update on reinitiating anticoagulation after temporary withdrawal of a vitamin K antagonist in patients with atrial fibrillation or venous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: McMaster University | Conditions: Atrial Fibrillation, Venous Thromboembolism | Phase 2 | Status: COMPLETED